RxDoctor Payments Data

Michael Lee

Orthopaedic Surgery of the Spine · Chicago, ILNPI 1881896652

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (40.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Globus Medical at 35.3% of the total. Reporting peaked in 2019 at $43,432 and has fallen 82.4% since, to $7,639 in 2025.

$107,222in general payments, 2019–2025

Across 168 payments — averaging $638.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$38K
  • Stryker$29K
  • Synthes GmbH$20K
  • Medical Device Business Services, Inc.$15K
  • Medtronic$4K
  • Revance Therapeutics, Inc.$430
  • plus $567 from 6 others

What the payments were for

  • Consulting fees$42,91840%
  • Speaking & faculty fees$38,75036%
  • Travel & lodging$20,77519%
  • Food & beverage$4,7804%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$107,222 in reported general payments places this provider in the 80th percentile of 64 orthopaedic surgery of the spine providers in Illinois.

See all orthopaedic surgery of the spine providers in Illinois

Medicare billing

Part B allowed, 2024
$272,291
Medicare patients
445
Services billed
854

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone22$134
Tramadol Hcl18$42

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →